Who
Dieter Weinand
Director
Company insider
Files Form 4 as: Director, Replimune Group; Director, Coya Therapeutics.
In numbers
- Trades disclosed
- 16
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 24 Jul 2018
- Last trade
- 1 Apr 2026
- Last filed
- 7 Apr 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Apr 2026filed 7 Apr 2026 | REPL Replimune Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,500 at $0.00 | filing |
| 1 Apr 2026filed 7 Apr 2026 | REPL Replimune Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,500 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | COYA Coya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | COYA Coya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 1 Apr 2025filed 3 Apr 2025 | REPL Replimune Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,000 at $0.00 | filing |
| 25 Feb 2025filed 25 Feb 2025 | COYA Coya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 1 Jan 2025filed 3 Jan 2025 | COYA Coya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 1 Apr 2024filed 3 Apr 2024 | REPL Replimune Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,000 at $0.00 | filing |
| 1 Jan 2024filed 19 Jan 2024 | COYA Coya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 18 Aug 2023filed 21 Aug 2023 | COYA Coya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 1 Apr 2023filed 4 Apr 2023 | REPL Replimune Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —37,800 at $0.00 | filing |
| 1 Apr 2022filed 5 Apr 2022 | REPL Replimune Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,750 at $0.00 | filing |
| 1 Apr 2021filed 5 Apr 2021 | REPL Replimune Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,750 at $0.00 | filing |
| 1 Apr 2020filed 2 Apr 2020 | REPL Replimune Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,750 at $0.00 | filing |
| 1 Apr 2019filed 3 Apr 2019 | REPL Replimune Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,500 at $0.00 | filing |
| 24 Jul 2018filed 26 Jul 2018 | REPL Replimune Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.